TY  - GEN
AU  - Bargiela,David
AU  - Bianchi,Matthew T
AU  - Westover,M Brandon
AU  - Chibnik,Lori B
AU  - Healy,Brian C
AU  - De Jager,Philip L
AU  - Xia,Zongqi
TI  - Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis
SN  - 1526-632X
PY  - 2017///0606
KW  - Adult
KW  - Clinical Decision-Making
KW  - methods
KW  - Decision Support Techniques
KW  - Disability Evaluation
KW  - Disease Progression
KW  - Female
KW  - Fingolimod Hydrochloride
KW  - adverse effects
KW  - Glatiramer Acetate
KW  - Humans
KW  - Immunologic Factors
KW  - Leukoencephalopathy, Progressive Multifocal
KW  - epidemiology
KW  - Male
KW  - Markov Chains
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - drug therapy
KW  - Natalizumab
KW  - Randomized Controlled Trials as Topic
KW  - Risk
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1212/WNL.0000000000003612
ER  -